DJIA 15,393.84 58.56 0.38%
NASDAQ 3,502.09 5.66 0.16%
S&P 500 1,671.06 4.77 0.29%

Elan

NYSE: ELN

+ Add to Portfolio

company name or ticker

Elan Proposes Sweeping Transformation

The company aims to make a raft of acquisitions.
5/20/2013 by DailyFinance

Biotech Companies: The FDA Doesn't Care About Your Phase 3 Trials

Results? Yes. Starting them? Not so much.
5/20/2013 by DailyFinance

Royalty Pharma Raises Takeover Bid for Elan

5/20/2013 by Smart Money

Elan’s Response to Royalty Pharma Announcement

5/20/2013 by DailyFinance

Elan Issues Response to Royalty Pharma Bid, Tells Holders to Take No Action

5/20/2013 by Benzinga

UPDATE: Royalty Pharma Confirms Increased $12.50/Share Cash Bid for Elan

5/20/2013 by Benzinga

Elan Announces Proposed Offering of US$800.0 Million in Aggregate Principal Amount of Senior Notes D

5/20/2013 by DailyFinance

Elan Announces Transactions: Decisively Transforming the Company

5/20/2013 by DailyFinance

This Week in Biotech

Clinical data and abstracts abound ahead of the American Society of Clinical Oncology's annual meeting.
5/18/2013 by DailyFinance

The Billion Dollar COPD Deal: Who Gains The Most?

5/17/2013 by Seeking Alpha
See More Articles...